Insmed (INSM) is a publicly traded Healthcare sector company. As of August 19, 2026, INSM trades at $128.36 with a market cap of $28.02B and a P/E ratio of -31.33. INSM moved +0.08% today. Year to date, INSM is -26.19%; over the trailing twelve months it is +0.94%. Its 52-week range spans $60.40 to $212.75. Analyst consensus is strong buy with an average price target of $201.06. Rallies surfaces INSM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Insmed (INSM) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. INSM moved +0.08% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $128.36 |
| Market Cap | $28.02B |
| P/E Ratio | -31.33 |
| EPS | $-4.10 |
| Dividend Yield | 0.00% |
| 52-Week High | $212.75 |
| 52-Week Low | $60.40 |
| Volume | 966.11K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.14B |
| Net Income | $-875.31M |
| Gross Margin | 83.45% |
19 analysts cover INSM: 0 strong buy, 19 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $201.06.